These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19967649)

  • 1. Transforming growth factor-beta as a treatment target in renal diseases.
    Fukuda N; Tahira Y; Matsuda H; Matsumoto K
    J Nephrol; 2009; 22(6):708-15. PubMed ID: 19967649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
    Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
    J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
    Qi W; Chen X; Poronnik P; Pollock CA
    Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines.
    Fukuda N
    Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
    Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
    J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S; Nyengaard JR; Wogensen L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
    Hilliard LM; Russo LM; Comper WD
    Am J Nephrol; 2009; 29(5):454-64. PubMed ID: 19023196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
    Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
    J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
    Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
    Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY; Kim BC; Lee HS
    Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta in renal injury and disease.
    Böttinger EP
    Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.